V009-7866 Screening compound: 2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-1,3-benzodiazole

V009-7866 Screening compound: 2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-1,3-benzodiazole
V009-7866 Screening compound: 2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-7866
2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-7866

Molecular Formula

C22H28F3N3O (C22 H28 F3 N3 O)

Compound Name

2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-1,3-benzodiazole

IUPAC name

2-methyl-1-[1-(4-methylcyclohexanecarbonyl)piperidin-4-yl]-5-(trifluoromethyl)-1H-13-benzodiazole

SMILES

CC(CC1)CCC1C(N(CC1)CCC1n1c(ccc(C(F)(F)F)c2)c2nc1C)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

407.48

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.854

Distribution Coefficient, logD

5.854

Water Solubility, LogSw

-5.59

Polar Surface Area

28.169

Acid Dissociation Constant (pKa)

22.48

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.60

V009-7866 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-7866 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-7866?
Check Price and Availability of V009-7866, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-7866 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-7866
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-7866
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-7866 available by request